🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts

Recruitingn/aAges 18 Years - anyAllJohns Hopkins University
NCT04473794 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients age 18 years and older * Referred for assessment of a pancreatic cyst. Exclusion Criteria: * Medically ill patients with American Society of Anesthesiologists class 4 or greater. * Inability to provide informed consent. * Pregnancy or lactation.
💊

What it tests

  • Not listed
📍

Where

1 site
The Johns Hopkins Hospital
Baltimore, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy